ArticleBone2013

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.

Nicola Napoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.